- Details
- Description
Packaging Size:
120 capsules
Strength:
40 mg
Composition:
Selpercatinib 40 mg
Treatment:
Targeted treatment for certain RET-altered cancers, including RET fusion-positive non-small cell lung cancer and certain RET-mutated or RET fusion-positive thyroid cancers
Form:
Hard capsule for oral use
Brand:
Selcaxen 40 mg
Quantity Unit:
Capsule
Manufacturer:
Everest Pharmaceuticals Ltd.
Selcaxen 40 mg contains selpercatinib, a targeted anticancer medicine that belongs to the RET kinase inhibitor class. It works by blocking abnormal RET signaling that can promote cancer cell growth and spread. Selcaxen is used to treat certain RET fusion-positive or RET-mutated cancers, including some forms of non-small cell lung cancer and thyroid cancer. It is an oral capsule and should be used under the supervision of an oncologist.
